MTD vs. QGEN: Mettler-Toledo vs. Qiagen Stock Comparison

November 11, 2026

How do Mettler-Toledo (MTD) and Qiagen (QGEN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Mettler-Toledo (MTD) and Qiagen (QGEN) are both classified in the Life Sciences Tools & Services sub-industry within the broader Life Sciences Tools & Services industry, placing them in the closest GICS peer bucket.

Company profile comparison for Mettler-Toledo (MTD) and Qiagen (QGEN)
Profile Item	MTD	QGEN
Name	Mettler-Toledo International Inc.	Qiagen N.V.
Country/Region	Switzerland	Netherlands
GICS Sector	Health Care	Health Care
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Pharmaceuticals, Biotechnology & Life Sciences
GICS Industry	Life Sciences Tools & Services	Life Sciences Tools & Services
GICS Sub-Industry	Life Sciences Tools & Services	Life Sciences Tools & Services
Market Capitalization	34.25 billion USD	10.39 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	November 14, 1997	June 28, 1996
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

MTD

QGEN

GSPC

Mettler-Toledo (MTD) vs. Qiagen (QGEN), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Mettler-Toledo (MTD) and Qiagen (QGEN). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Mettler-Toledo (MTD) and Qiagen (QGEN). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Mettler-Toledo (MTD) and Qiagen (QGEN)
Metric	MTD	QGEN
Total Return (1Y)	21.58%	17.09%
Total Return (3Y, Annualized)	19.54%	10.44%
Total Return (5Y, Annualized)	2.36%	-0.72%

Risk Profile

Drawdown History

MTD

QGEN

GSPC

Mettler-Toledo (MTD) vs. Qiagen (QGEN), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Mettler-Toledo (MTD) and Qiagen (QGEN). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Mettler-Toledo (MTD) and Qiagen (QGEN)
Metric	MTD	QGEN
Volatility (1Y, Annualized)	31.70%	35.52%
Beta (5Y)	1.15	0.56
Max Drawdown (5Y)	-43.47%	-41.97%
Avg. Volume (3M)	197.80K	3.68M

Risk-Adjusted Performance

Risk-Return Positioning

MTD and QGEN are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Mettler-Toledo (MTD) and Qiagen (QGEN)
Metric	MTD	QGEN
Sharpe Ratio (1Y)	0.55	0.36
Sortino Ratio (1Y)	0.75	0.60

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Qiagen (QGEN) earns 10.81% on shareholders’ equity, ranked against its industry; Mettler-Toledo (MTD) has no ROE this period.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 109.18%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%
MTD: --

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

10.81%

Max: 109.18%
QGEN: 10.81%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%

Mettler-Toledo (MTD) vs. Qiagen (QGEN): MTD does not report ROE, so it has no value marker; QGEN is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

Both Mettler-Toledo (MTD) at 22.25% and Qiagen (QGEN) at 18.20% keep an unusually large share of revenue as bottom-line profit — each net margin clears its industry’s benchmark range.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

22.25%

MTD: 22.25%
Max: 18.05%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.20%

QGEN: 18.20%
Max: 18.05%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Both Mettler-Toledo (MTD) at 28.70% and Qiagen (QGEN) at 27.75% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

28.70%

Max: 83.12%
MTD: 28.70%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.75%

Max: 83.12%
QGEN: 27.75%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Mettler-Toledo (MTD) and Qiagen (QGEN)
Metric	MTD	QGEN
ROE (TTM)	--	10.81%
ROA (TTM)	20.09%	5.68%
Net Margin (TTM)	22.25%	18.20%
Operating Margin (TTM)	28.70%	27.75%
Gross Margin (TTM)	59.16%	67.06%

Growth

Revenue Growth

Both Mettler-Toledo (MTD) at 3.98% and Qiagen (QGEN) at 5.65% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their Revenue Growth across different time periods.

EPS Growth

Qiagen (QGEN) at 409.76% clears its industry range for EPS growth, a much stronger earnings trajectory than Mettler-Toledo (MTD) at 3.88%, which is closer to a typical peer reading.

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Mettler-Toledo (MTD) and Qiagen (QGEN)
Metric	MTD	QGEN
Revenue Growth (YoY)	3.98%	5.65%
Revenue Growth (3Y CAGR)	0.90%	-0.81%
EPS Growth (YoY)	3.88%	409.76%
EPS Growth (3Y CAGR)	3.06%	-0.19%

Financial Strength

Current Ratio (MRQ)

Qiagen (QGEN) at 2.63 keeps current ratio within its industry’s typical mid-range, while Mettler-Toledo (MTD) at 1.10 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for MTD.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.10

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
MTD: 1.10
Min: 0.10

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.63

Max: 25.13
Q3: 12.13
Median: 5.52
QGEN: 2.63
Q1: 2.47
Min: 0.10

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Qiagen (QGEN) at 0.47 is near its industry mid-range for debt-to-equity ratio, while Mettler-Toledo (MTD) at 26.06 sits above its benchmark range, pointing to a heavier debt load relative to equity.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

26.06

MTD: 26.06
Max: 1.42
Q3: 0.65
Median: 0.15
Q1: 0.02
Min: 0.00

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.47

Max: 1.42
Q3: 0.65
QGEN: 0.47
Median: 0.15
Q1: 0.02
Min: 0.00

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Mettler-Toledo (MTD) and Qiagen (QGEN)
Metric	MTD	QGEN
Current Ratio (MRQ)	1.10	2.63
Debt / Equity (MRQ)	26.06	0.47
Net Debt / EBITDA	1.58	1.08

Dividends

Dividend Yield (TTM)

Mettler-Toledo (MTD) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Qiagen (QGEN) reports a yield of 0.71%, ranking against industry peers normally.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

MTD: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.71%

QGEN: 0.71%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Mettler-Toledo (MTD) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Qiagen (QGEN) reports a payout of 18.21%, ranking against industry peers normally.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

MTD: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.21%

QGEN: 18.21%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Mettler-Toledo (MTD) and Qiagen (QGEN)
Metric	MTD	QGEN
Dividend Yield (TTM)	0.00%	0.71%
Dividend Payout Ratio (TTM)	0.00%	18.21%

Valuation

P/E Ratio (TTM)

Both Mettler-Toledo (MTD) at 37.38 and Qiagen (QGEN) at 27.21 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

37.38

Max: 85.34
Q3: 43.46
MTD: 37.38
Median: 26.69
Q1: 13.30
Min: 0.07

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.21

Max: 85.34
Q3: 43.46
QGEN: 27.21
Median: 26.69
Q1: 13.30
Min: 0.07

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

On P/S ratio, both Mettler-Toledo (MTD) at 8.16 and Qiagen (QGEN) at 4.91 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.16

Max: 58.18
Q3: 25.77
MTD: 8.16
Median: 7.30
Q1: 3.01
Min: 0.01

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.91

Max: 58.18
Q3: 25.77
Median: 7.30
QGEN: 4.91
Q1: 3.01
Min: 0.01

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Qiagen (QGEN) at 2.99 sits near its industry’s typical P/B ratio, while Mettler-Toledo (MTD) at 442.71 prices above its benchmark range — MTD looks rich relative to book.

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

442.71

MTD: 442.71
Max: 13.53
Q3: 6.54
Median: 3.25
Q1: 1.69
Min: -5.59

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.99

Max: 13.53
Q3: 6.54
Median: 3.25
QGEN: 2.99
Q1: 1.69
Min: -5.59

Mettler-Toledo (MTD) vs. Qiagen (QGEN): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Mettler-Toledo (MTD) and Qiagen (QGEN)
Metric	MTD	QGEN
P/E Ratio (TTM)	37.38	27.21
P/S Ratio (TTM)	8.16	4.91
P/B Ratio (MRQ)	442.71	2.99
Free Cash Flow Yield (TTM)	1.97%	3.62%